Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

CANNAPHARMARX, INC. (CPMD) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

CANNAPHARMARX, INC. (CPMD), most recent 12 months reported: revenue $1.7M, net loss $11.32M. From SEC filings. Others in Pharmaceutical Preparations: CYCLERION THERAPEUTICS, INC. · Dianthus Therapeutics, Inc. /DE/ · ORAMED PHARMACEUTICALS INC. · Seres Therapeutics, Inc. · Ovid Therapeutics Inc. · LIPOCINE INC. · Cartesian Therapeutics, Inc. · AVENUE THERAPEUTICS, INC.

Stock screener

Watchlist